COMPOUNDS FOR TREATING RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
申请人:MITCHELL Jeffrey Peter
公开号:US20110207728A1
公开(公告)日:2011-08-25
The present invention relates to compounds of formula (I)
its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.
Substituted imidazo[1,2-α]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus (RSV) infections
申请人:Mitchell Jeffrey Peter
公开号:US08604034B2
公开(公告)日:2013-12-10
The present invention relates to compounds of formula (I)
its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.
Substituted imidazo[1,2-a]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections
申请人:Biota Scientific Management Pty Ltd.
公开号:US09163029B2
公开(公告)日:2015-10-20
The present invention relates to compounds of formula (I)
its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.
Compounds for Treating Respiratory Syncytial Virus Infections
申请人:BIOTA SCIENTIFIC MANAGEMENT PTY LTD.
公开号:US20160046642A1
公开(公告)日:2016-02-18
The present invention relates to compounds of formula (I)
its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.